Amarantus Bioscience Holdings, Inc. (OTCMKTS:AMBS) Climbs Further Up The Charts

[[tagnumber 0]][[tagnumber 1]]Amarantus Bioscience Holdings, Inc. (OTCMKTS:AMBS)’s shareholders suffered a lot in the month of March, as the stock took a serious dive down the charts, losing nearly 50% of its price. We saw the ticker get more stable and fluctuate between the $0.045 and $0.050 mark in April and the beginning of this month.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]All the while, [[tagnumber 6]]AMBS [[tagnumber 7]]was issuing optimistic press releases that managed to do little for the company stock. The company also failed to file its report for Q1 of this year in time. The latest numbers contained in their report for 2014 weren’t that impressive, considering [[tagnumber 6]]AMBS [[tagnumber 7]]is worth upward of $60 million.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 13]] [[tagnumber 14]]cash: $214 thousand[[tagnumber 15]] [[tagnumber 14]]current assets: $412 thousand[[tagnumber 15]] [[tagnumber 14]]current liabilities: $6.32 million[[tagnumber 15]] [[tagnumber 14]]yearly revenues: ZERO[[tagnumber 15]] [[tagnumber 14]]yearly net loss: $5.92 million[[tagnumber 15]] [[tagnumber 24]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Still, [[tagnumber 6]]AMBS [[tagnumber 7]]did manage to gain some ground recently. It has closed the last 4 sessions in the green and it seems as though it is attempting to reach its previous levels. The ticker added 10.31% to its value in yesterday’s session and closed at $0.006, generating $440 thousand in daily dollar volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The most recent press release came earlier today and it announced that [[tagnumber 6]]AMBS [[tagnumber 7]]will present at two upcoming investor conferences in New York and Los Angeles. This isn’t such a big thing, but it can surely keep investors’ confidence in the company stock.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Today has started rather slow, but [[tagnumber 6]]AMBS [[tagnumber 7]]is still in the green. That, however, doesn’t mean that you should skip on doing your due diligence and weighing out the risks before putting any money on the line.[[tagnumber 2]]